» Articles » PMID: 39062799

A Rare Coincidence of Three Inherited Diseases in a Family with Cardiomyopathy and Multiple Extracardiac Abnormalities

Abstract

A genetic diagnosis of primary cardiomyopathies can be a long-unmet need in patients with complex phenotypes. We investigated a three-generation family with cardiomyopathy and various extracardiac abnormalities that had long sought a precise diagnosis. The 41-year-old proband had hypertrophic cardiomyopathy (HCM), left ventricular noncompaction, myocardial fibrosis, arrhythmias, and a short stature. His sister showed HCM, myocardial hypertrabeculation and fibrosis, sensorineural deafness, and congenital genitourinary malformations. Their father had left ventricular hypertrophy (LVH). The proband's eldest daughter demonstrated developmental delay and seizures. We performed a clinical examination and whole-exome sequencing for all available family members. All patients with HCM/LVH shared a c.4411-2A>C variant in , a recently known HCM-causative gene. Functional studies confirmed that this variant alters canonical splicing. Due to extracardiac symptoms in the female patients, we continued the search and found two additional single-gene disorders. The proband's sister had a p.Trp329Gly missense in , linked to hypoparathyroidism, sensorineural deafness, and renal dysplasia; his daughter had a p.Ser251del in , associated with beta-propeller protein-associated neurodegeneration. This unique case of three monogenic disorders in one family shows how a comprehensive approach with thorough phenotyping and extensive genetic testing of all symptomatic individuals provides precise diagnoses and appropriate follow-up, embodying the concept of personalized medicine. We also present the first example of a splicing functional study for and describe the genotype-phenotype correlations in cardiomyopathy.

References
1.
Dyle M, Kolakada D, Cortazar M, Jagannathan S . How to get away with nonsense: Mechanisms and consequences of escape from nonsense-mediated RNA decay. Wiley Interdiscip Rev RNA. 2019; 11(1):e1560. PMC: 10685860. DOI: 10.1002/wrna.1560. View

2.
Gahl W, Mulvihill J, Toro C, Markello T, Wise A, Ramoni R . The NIH Undiagnosed Diseases Program and Network: Applications to modern medicine. Mol Genet Metab. 2016; 117(4):393-400. PMC: 5560125. DOI: 10.1016/j.ymgme.2016.01.007. View

3.
Al Senaidi K, Joshi N, Al-Nabhani M, Al-Kasbi G, Al Farqani A, Al-Thihli K . Phenotypic spectrum of ALPK3-related cardiomyopathy. Am J Med Genet A. 2019; 179(7):1235-1240. DOI: 10.1002/ajmg.a.61176. View

4.
Hoss S, Habib M, Silver J, Care M, Chan R, Hanneman K . Genetic Testing for Diagnosis of Hypertrophic Cardiomyopathy Mimics: Yield and Clinical Significance. Circ Genom Precis Med. 2020; 13(2):e002748. DOI: 10.1161/CIRCGEN.119.002748. View

5.
Phelan D, Anderson D, Howden S, Wong R, Hickey P, Pope K . ALPK3-deficient cardiomyocytes generated from patient-derived induced pluripotent stem cells and mutant human embryonic stem cells display abnormal calcium handling and establish that ALPK3 deficiency underlies familial cardiomyopathy. Eur Heart J. 2016; 37(33):2586-90. DOI: 10.1093/eurheartj/ehw160. View